Independent fund research. Built on SEC filings.

How we research funds

ETF · International Stock · Transamerica

Brandes International ETF (BINV)

Ticker BINV · Since 2023-10-04 · · Holdings as of Jun 30, 2026

Expense ratio
0.7%$70/yr per $10k
1-yr return
+37.6%as of Dec 2025
Net assets
$490.1Mall share classes
Holdings
67

Bottom line

Is BINV a good fund? The bottom line

BINV is a managed international stock ETF from Transamerica.

It charges 0.7% — about $70 a year on every $10,000 invested, cheaper than 71% of international stock funds we track.

It returned +37.6% over one year (as of Dec 31, 2025, per its prospectus).

With $490 million in net assets and 67 holdings, its largest position is Sanofi Sa (3.1%) and the top 10 make up 23% of the portfolio.

Updated Nov 19, 2026

What BINV invests in

The Brandes International ETF (the Fund) seeks long term capital appreciation.

The Fund is an actively managed exchange-traded fund (ETF) that seeks to attain its investment objective by investing primarily in equity securities of foreign companies. The types of equity securities in which the Fund invests are common and preferred stocks, American Depositary Receipts (ADRs), and warrants and rights. The Fund typically invests in foreign companies with market capitalizations (market value of publicly traded equity securities) greater than $5 billion at the time of purchase. A foreign company is determined to be foreign on the basis of its domicile being outside the U.S., its principal place of business being outside the U.S., its primary stock exchange listing being outside the U.S., and/or at least 50% of its revenues being derived from goods sold or produced, investments made, or services performed outside the U.S. Under normal market conditions, the Fund will…

From the fund's prospectus (filed Oct 28, 2026).

BINV performance

Fund calendar-year total returns, 2024–2025 2024: +7.7%; 2025: +37.6% +7.7% 2024 +37.6% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
BINV+37.6%——
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2025

Full BINV performance history →

What BINV costs

On a $10,000 investment, BINV's 0.7% expense ratio costs about $70 a year. The prospectus estimates $871 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full BINV fee table →

BINV top 10 holdings

#Holding% of fund
1Sanofi Sa SAN3.10%
2Sap Se SAP2.58%
3Takeda Pharmaceutical Company Ltd 45022.35%
4Alibaba Group Holding Ltd BABA2.34%
5Henkel Ag & Co. Kgaa HEN2.33%
6Wal-mart De Mexico Sab De Cv (wal-mart De Mexico Sa De Cv) WALMEX*2.29%
7Compagnie Financiere Richemont Sa CFR2.10%
8Heineken Holding Nv HEIO2.06%
9Reckitt Benckiser Group Plc1.92%
10Dsm Firmenich Ag DSFIR1.91%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 23% of the fund. See all top 25 holdings and asset mix →

Alternatives to BINV

More funds like BINV →

BINV FAQ

What is the expense ratio of BINV?
BINV's expense ratio is 0.7%, which works out to about $70 a year for every $10,000 invested. The prospectus estimates total costs of $871 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BINV a good investment?
It depends on your goals, but the data points to: a typical fund for its category. This is general information, not personalized advice.
What does BINV hold?
BINV's largest holdings are Sanofi Sa (3.1%), Sap Se (2.6%), Takeda Pharmaceutical Company Ltd (2.3%), Alibaba Group Holding Ltd (2.3%), Henkel Ag & Co. Kgaa (2.3%). It holds 67 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages BINV?
BINV is offered by Transamerica through 2023 ETF Series Trust.